Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.07.2020 | Case report

Hormonal replacements/progesterone receptor agonists/progesterone congeners

Breast cancer and vascular disorders: 8 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Dias D, et al. Is Gonadal Therapy a Promoter of Breast Cancer? Incidence of Breast Cancer in a Cohort of Survivors of Oncological Diseases Treated with Gonadal Steroids. Case Reports in Oncology 13: 347-357, No. 1, Jan-Apr 2020. Available from: URL: http://doi.org/10.1159/000506395 Dias D, et al. Is Gonadal Therapy a Promoter of Breast Cancer? Incidence of Breast Cancer in a Cohort of Survivors of Oncological Diseases Treated with Gonadal Steroids. Case Reports in Oncology 13: 347-357, No. 1, Jan-Apr 2020. Available from: URL: http://​doi.​org/​10.​1159/​000506395
Metadaten
Titel
Hormonal replacements/progesterone receptor agonists/progesterone congeners
Breast cancer and vascular disorders: 8 case reports
Publikationsdatum
01.07.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-80873-y

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Adalimumab

Case report

Fluorouracil

Case report

Rivoceranib

Case report

Risperidone

Case report

Antineoplastics

Case report

Rituximab